STOCK TITAN

Ashland Inc. - ASH STOCK NEWS

Welcome to our dedicated page for Ashland news (Ticker: ASH), a resource for investors and traders seeking the latest updates and insights on Ashland stock.

Ashland Inc. (NYSE: ASH) is a premier global specialty chemicals company that serves a wide range of consumer and industrial markets. With a workforce of nearly 7,000 passionate professionals, including renowned scientists, research chemists, talented engineers, and plant operators, Ashland thrives on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries.

Operating in four distinct segments—Life Sciences, Personal Care, Specialty Additives, and Intermediates—Ashland is a key supplier to pharmaceutical companies, manufacturers of personal care products, food and beverages, nutraceuticals, and supplements. The Life Sciences segment generates the highest revenue, reflecting the company’s strong focus on this area.

Recently, Ashland announced significant organizational changes within its finance, strategy, mergers and acquisitions (M&A), and portfolio teams. The company has also issued its first-quarter financial results for fiscal year 2024 and outlined its outlook for the second quarter and full year. Ashland's leadership positions in high-quality, consumer-focused markets such as pharmaceuticals, personal care, and architectural coatings underline its commitment to excellence.

Ashland continues to foster gender equity and empowerment by spotlighting inspirational female employees, particularly in recognition of International Women’s Day. The company recently increased its support for greenlight4girls, a global initiative to inspire girls in STEM fields.

In line with its strategic goals, Ashland has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC. The transaction, expected to close in the third quarter of 2024, is subject to customary closing conditions.

For the latest updates and more detailed information, visit the official Ashland website and the Investor Relations section.

Rhea-AI Summary

Ashland (NYSE: ASH) has announced that its board of directors has declared a quarterly cash dividend of $0.405 per share on the company's common stock. The dividend will be paid on March 15, 2025, to stockholders of record as of March 1, 2025. The company reported 47,182,862 outstanding shares of common stock as of December 31, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
Rhea-AI Summary

Ashland Inc. (NYSE: ASH) has announced it will release its first-quarter fiscal 2025 earnings report on Tuesday, January 28, 2025, at approximately 5 p.m. ET. The company will host a live webcast with securities analysts on Wednesday, January 29 at 9 a.m. ET, featuring an executive summary and detailed remarks.

Key executives participating in the presentation include Chair and CEO Guillermo Novo, CFO Kevin Willis, and several senior vice presidents. A slide presentation will be available simultaneously on the company's Investor Relations website. Participants are encouraged to register for phone access and dial in fifteen minutes before the scheduled start time. The webcast and supporting materials will remain accessible on Ashland's website for 12 months following the live event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
conferences earnings
-
Rhea-AI Summary

Ashland Inc. (NYSE: ASH) has announced a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in Q1 2025, subject to customary closing conditions. Avoca, which represents the final entity from Ashland's previous Pharmachem acquisition, operates two production facilities in North Carolina and Wisconsin, specializing in Sclareolide (a fragrance fixative) and contract manufacturing capabilities. Squire Patton Boggs is serving as Ashland's legal advisor for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
none
Rhea-AI Summary

Ingevity (NYSE:NGVT) has elected J. Kevin Willis to its board of directors, expanding the board to nine members, with eight being independent. Willis currently serves as senior vice president and CFO at Ashland Inc. (NYSE:ASH), where he oversees worldwide financial functions and participates in global strategy setting. During his 37-year tenure at Ashland, Willis has accumulated extensive experience in accounting, finance, and treasury management, including international operations. His expertise includes driving shareholder value through capital allocation planning, operating efficiencies, and business portfolio separations, notably Ashland's separation from Valvoline.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
management
-
Rhea-AI Summary

Ashland Inc. (NYSE: ASH) marked its 100-year anniversary by ringing the opening bell at the New York Stock Exchange on December 9, 2024. CEO Guillermo Novo and company executives participated in this historic tradition that dates back to 1792.

The company has evolved from an oil and refining company to a focused additives and specialty ingredients company. One year ago, Ashland introduced seven new technology platforms aligned with its pharmaceutical, personal care, and specialty additives core, offering sustainable innovations to customers worldwide.

Ashland announced a strategy update event scheduled for December 10, 2024, in New York City. The event will provide an in-depth review of strategic priorities, initiatives, and financial objectives for fiscal year 2025. Despite challenges from inventory destocking in the materials sector, the company achieved margin expansion and high-quality free cash flow.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
none
-
Rhea-AI Summary

Ashland Inc. (NYSE: ASH) has announced a strategic partnership with the Arbor Day Foundation to plant 15,200 native trees, marking the company's 100-year anniversary. The initiative spans across Brazil, Mexico, and several U.S. states including Kentucky, West Virginia, Alabama, Mississippi, Georgia, and Florida.

The project includes specific focuses: Amazon rainforest reforestation (2,500 trees), wildlife corridor creation in Mexico (2,000 trees), former coal mine land restoration in the Central Appalachian Region (2,700 trees), and hurricane and flooding restoration in Gulf Coastal Forests (8,000 trees).

This initiative aligns with Ashland's recent commitment to Science based Targets initiative (SBTi) and their October 2023 formal approval of science-based targets addressing scope one, two and three emissions. The company emphasizes sustainable sourcing and innovation in personal care, architectural coatings, and life sciences through natural raw materials like cellulose and guar.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
none
Rhea-AI Summary

Ashland (NYSE: ASH) has announced its board of directors has declared a quarterly cash dividend of $0.405 per share on common stock. The dividend will be paid on December 15, 2024, to stockholders of record as of December 1, 2024. The company reported 47,109,326 outstanding shares of common stock as of October 31, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
dividends
-
Rhea-AI Summary

Ashland (NYSE: ASH) has announced a strategy update event for analysts and investors scheduled for December 10, 2024, in New York City. The event will feature presentations from Ashland's executive team, focusing on strategic priorities, key initiatives, and financial objectives for fiscal year 2025.

The session will run from 9:00 AM to 11:00 AM ET, followed by breakout sessions until noon for in-person attendees. Both in-person and webcast participants will have opportunities to engage in Q&A sessions.

Key presenters include Chair and CEO Guillermo Novo, CFO Kevin Willis, and senior leadership from specialty additives, life sciences, and personal care divisions. Registration is required, with in-person seating available. A webcast replay will be accessible for 12 months on Ashland's investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
conferences
-
Rhea-AI Summary

Ashland Inc. (NYSE: ASH) reported Q4 fiscal 2024 financial results with sales of $522 million, up 1% year-over-year. Income from continuing operations was $19 million ($0.39 per diluted share), while adjusted EBITDA increased 68% to $124 million. The company faced challenges including HEC operating issues ($5 million impact) and softer coatings demand in China. Notable developments include the sale of nutraceuticals business to Turnspire Capital Partners and portfolio optimization initiatives that reduced overall sales by $24 million. The company repurchased 1.7 million shares and generated $88 million in ongoing free cash flow. For fiscal 2025, Ashland expects sales between $1.90-2.05 billion and adjusted EBITDA of $430-470 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.64%
Tags
Rhea-AI Summary

Ashland Inc. (NYSE: ASH) has announced it will release its fourth-quarter fiscal 2024 earnings on Wednesday, November 6, 2024, at approximately 5 p.m. ET. The company will host a live webcast with securities analysts at 9 a.m. ET on Thursday, November 7, featuring an executive summary and detailed remarks. A slide presentation will be available in the Investor Relations section of the company's website. Key executives participating include Chair and CEO Guillermo Novo, CFO Kevin Willis, and other senior management team members. The webcast and supporting materials will be accessible through Ashland's website for 12 months after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
conferences earnings

FAQ

What is the current stock price of Ashland (ASH)?

The current stock price of Ashland (ASH) is $71.43 as of January 20, 2025.

What is the market cap of Ashland (ASH)?

The market cap of Ashland (ASH) is approximately 3.4B.

What does Ashland Inc. specialize in?

Ashland Inc. is a global specialty chemicals company that serves a variety of consumer and industrial markets, including pharmaceuticals, personal care, food and beverage, and more.

How many employees does Ashland Inc. have?

Ashland Inc. employs nearly 7,000 passionate professionals who work in various scientific, engineering, and operational roles.

What are the main business segments of Ashland Inc.?

Ashland Inc. operates in four main segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates.

Who are some of Ashland Inc.'s key customers?

Key customers include pharmaceutical companies, manufacturers of personal care products, food and beverages, and nutraceuticals and supplements.

What recent organizational changes has Ashland Inc. announced?

Ashland Inc. announced changes to its finance, strategy, mergers and acquisitions (M&A), and portfolio teams, effective immediately.

How does Ashland Inc. support gender equity?

Ashland Inc. supports gender equity by recognizing inspirational female employees and increasing its support for initiatives like greenlight4girls.

What strategic transaction did Ashland Inc. recently announce?

Ashland Inc. announced a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC, expected to close in the third quarter of 2024.

Where can I find Ashland Inc.'s financial updates?

Financial updates are available in the Investor Relations section of the Ashland website at http://investor.ashland.com.

What is Ashland Inc.'s ticker symbol and where is it listed?

Ashland Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol ASH.

What are some key markets served by Ashland Inc.?

Ashland Inc. serves key markets including adhesives, architectural coatings, automotive, construction, energy, food and beverage, personal care, and pharmaceutical.
Ashland Inc.

NYSE:ASH

ASH Rankings

ASH Stock Data

3.37B
46.67M
1.02%
96.32%
2.33%
Specialty Chemicals
Wholesale-chemicals & Allied Products
Link
United States of America
WILMINGTON